Dkk3gene therapy is in clinical trial for prostate cancer with promisingresults41, but further preclinical evaluation isnecessary alongside more detailed investigation of the role of Dkk3 in othertissues of the healthy and OA joint. Here, DKK3 is linked to prostate carcinoma.